436 related articles for article (PubMed ID: 15263040)
1. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients.
Lawrence DP; Kupelnick B; Miller K; Devine D; Lau J
J Natl Cancer Inst Monogr; 2004; (32):40-50. PubMed ID: 15263040
[TBL] [Abstract][Full Text] [Related]
2. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
3. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based treatment for cancer-related fatigue.
Mock V
J Natl Cancer Inst Monogr; 2004; (32):112-8. PubMed ID: 15263051
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention.
Stricker CT; Drake D; Hoyer KA; Mock V
Oncol Nurs Forum; 2004 Sep; 31(5):963-76. PubMed ID: 15378097
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related fatigue.
Stone PC; Minton O
Eur J Cancer; 2008 May; 44(8):1097-104. PubMed ID: 18381237
[TBL] [Abstract][Full Text] [Related]
7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
8. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors.
van Weert E; Hoekstra-Weebers JE; May AM; Korstjens I; Ros WJ; van der Schans CP
Patient Educ Couns; 2008 May; 71(2):169-90. PubMed ID: 18255249
[TBL] [Abstract][Full Text] [Related]
9. Physical activity in the management of cancer-related fatigue induced by oncological treatments.
Labourey JL
Ann Readapt Med Phys; 2007 Jul; 50(6):450-4, 445-9. PubMed ID: 17399841
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
Chu E; Einhorn LH; Lefebvre P
J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
[TBL] [Abstract][Full Text] [Related]
14. Cancer-related fatigue: guidelines for evaluation and management.
Portenoy RK; Itri LM
Oncologist; 1999; 4(1):1-10. PubMed ID: 10337366
[TBL] [Abstract][Full Text] [Related]
15. Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
Curr Med Res Opin; 2005; 21 Suppl 2():S12-5. PubMed ID: 15969861
[TBL] [Abstract][Full Text] [Related]
16. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
Curr Med Res Opin; 2005; 21 Suppl 2():S3-5. PubMed ID: 15969858
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related fatigue: evolving concepts in evaluation and treatment.
Stasi R; Abriani L; Beccaglia P; Terzoli E; Amadori S
Cancer; 2003 Nov; 98(9):1786-801. PubMed ID: 14584059
[TBL] [Abstract][Full Text] [Related]
18. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
19. Fatigue in older cancer patients: etiology, assessment, and treatment.
Rao AV; Cohen HJ
Semin Oncol; 2008 Dec; 35(6):633-42. PubMed ID: 19027467
[TBL] [Abstract][Full Text] [Related]
20. [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].
Dielenseger P; Dilhuydy JM; Brusco S; Chazot L; Blay JY; Bové B; Colcanap B; Ferrandez JC; Floquet A; Jane Gledhill ; Hubert N; Meslier M; Rosman S; Carretier J; Delavigne V; Fervers B; Leichtnam-Dugarin L; Philip T; ; ; ; ; ; ; ; ;
Bull Cancer; 2006 Dec; 93(12):1213-27. PubMed ID: 17191350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
